Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2015 by University of California, Los Angeles
Sponsor:
Collaborator:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Marco Giovannini, M.D.,Ph.D., University of California, Los Angeles
ClinicalTrials.gov Identifier:
NCT01345136
First received: April 21, 2011
Last updated: February 19, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2017
  Estimated Primary Completion Date: February 2017 (Final data collection date for primary outcome measure)